Selected article for: "data extraction and international license"
Author: Eric Anthony Coomes; Hourmazd Haghbayan
Title: Interleukin-6 in COVID-19: A Systematic Review and Meta-Analysis
  • Document date: 2020_4_3
    • ID: nadcsiii_12
    Snippet: Data extraction was undertaken in duplicate (E.A.C. and H.H.) via standardized data extraction tables. Data were extracted from article text, tables, and graphs (employing figure analysis tools to quantitatively estimate curves for data). Data were collected for study design and setting, patient demographics, disease characteristics, levels of immune markers and . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, w.....
    Document: Data extraction was undertaken in duplicate (E.A.C. and H.H.) via standardized data extraction tables. Data were extracted from article text, tables, and graphs (employing figure analysis tools to quantitatively estimate curves for data). Data were collected for study design and setting, patient demographics, disease characteristics, levels of immune markers and . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • analysis tool and cc NC ND International license: 1, 2
    • analysis tool and data extraction: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • analysis tool and International license: 1, 2, 3
    • analysis tool and study design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • article text and data extraction: 1, 2, 3
    • article text and study design: 1, 2, 3, 4, 5
    • cc NC ND International license and data extraction: 1
    • cc NC ND International license and disease characteristic: 1, 2
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and patient demographic: 1
    • cc NC ND International license and study design: 1, 2, 3, 4, 5, 6
    • data extraction and International license: 1, 2, 3, 4
    • data extraction and patient demographic: 1, 2
    • data extraction and study design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • data extraction table and study design: 1, 2
    • disease characteristic and International license: 1, 2
    • disease characteristic and study design: 1
    • immune marker and International license: 1
    • immune marker and study design: 1, 2